We are live on ! Find out more
TC

Trilogy Capital Portfolio holdings

AUM $2.58B
1-Year Est. Return 22.97%
This Fund
S&P 500
This Quarter Est. Return
+0.56%
1 Year Est. Return
+22.97%
3 Year Est. Return
+54.11%
5 Year Est. Return
+45.31%
10 Year Est. Return
–
AUM
$743M
AUM Growth
+$53.3M
Cap. Flow
+$51.3M
Cap. Flow %
6.9%
Top 10 Hldgs %
53.39%
Holding
654
New
146
Increased
170
Reduced
82
Closed
37

Top Buys

Rank Stock Value
1
SPAB icon
State Street SPDR Portfolio Aggregate Bond ETF
SPAB
+$5.25M
2
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
+$4.23M
3
VTI icon
Vanguard Total Stock Market ETF
VTI
+$3.43M
4
SPDW icon
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
+$3.4M
5
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$2.78M

Top Sells

Rank Stock Value
1
SPSB icon
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
+$1.7M
2
SDY icon
State Street SPDR S&P Dividend ETF
SDY
+$339K
3
MON
Monsanto Co
MON
+$315K
4
DKS icon
Dick's Sporting Goods
DKS
+$265K
5
BKE icon
Buckle
BKE
+$260K

Sector Composition

Rank Sector Weight
1 Utilities 1.73%
2 Consumer Staples 1.32%
3 Healthcare 0.81%
4 Consumer Discretionary 0.65%
5 Technology 0.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CHRD icon
451
Chord Energy
CHRD
$7.79B
$2K ﹤0.01%
125
– –
CM icon
452
Canadian Imperial Bank of Commerce
CM
$107B
$2K ﹤0.01%
+50
New +$2.2K
CVS icon
453
CVS Health
CVS
$137B
$2K ﹤0.01%
33
– –
CW icon
454
Curtiss-Wright
CW
$27.7B
$2K ﹤0.01%
19
– –
CX icon
455
Cemex
CX
$17.4B
$2K ﹤0.01%
350
– –
DHS icon
456
WisdomTree US High Dividend Fund
DHS
$1.56B
$2K ﹤0.01%
23
– –
EBAY icon
457
eBay
EBAY
$48.6B
$2K ﹤0.01%
58
– –
GPRO icon
458
GoPro
GPRO
$116M
$2K ﹤0.01%
265
– –
HAL icon
459
Halliburton
HAL
$27.9B
$2K ﹤0.01%
35
-18
-34% -$896
HOG icon
460
Harley-Davidson
HOG
$2.68B
$2K ﹤0.01%
50
– –
HTH icon
461
Hilltop Holdings
HTH
$2.29B
$2K ﹤0.01%
102
+1
+1% +$23
IJT icon
462
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.22B
$2K ﹤0.01%
+26
New +$2.39K
ING icon
463
ING
ING
$93.8B
$2K ﹤0.01%
118
– –
IONS icon
464
Ionis Pharmaceuticals
IONS
$9.35B
$2K ﹤0.01%
37
– –
ITB icon
465
iShares US Home Construction ETF
ITB
$2.41B
$2K ﹤0.01%
52
– –
IX icon
466
ORIX
IX
$44B
$2K ﹤0.01%
150
– –
KLAC icon
467
KLA
KLAC
$275B
$2K ﹤0.01%
170
+50
+42% +$544
MIN
468
Aberdeen Intermediate Income Fund
MIN
$273M
$2K ﹤0.01%
599
+13
+2% +$50
MTD icon
469
Mettler-Toledo International
MTD
$26.8B
$2K ﹤0.01%
3
– –
NVO
470
Novo Nordisk
NVO
$216B
$2K ﹤0.01%
98
– –
OMF icon
471
OneMain Financial
OMF
$6.9B
$2K ﹤0.01%
68
– –
PCK
472
DELISTED
Pimco California Municipal Income Fund II
PCK
$2K ﹤0.01%
254
+4
+2% +$33
PEB icon
473
Pebblebrook Hotel Trust
PEB
$2.16B
$2K ﹤0.01%
40
– –
RF icon
474
Regions Financial
RF
$26.3B
$2K ﹤0.01%
116
– –
RYAAY icon
475
Ryanair
RYAAY
$29.5B
$2K ﹤0.01%
35
– –
17 18
19
20 21

Similar funds

GFA
Gallagher Fiduciary Advisors Rolling Meadows, Illinois $2.58B AUM 8.97% 1-Year Est. Return
LS
Livforsakringsbolaget Skandia Stockholm, Sweden $2.58B AUM 30.64% 1-Year Est. Return
RG
Rakuten Group Setagaya-Ku, Tokyo, Japan $2.58B AUM 250.19% 1-Year Est. Return
AAS
Ameritas Advisory Services Lincoln, Nebraska $2.58B AUM 18.84% 1-Year Est. Return
DCM
Dorsal Capital Management Redwood City, California $2.57B AUM 3.13% 1-Year Est. Return
GWP
Gateway Wealth Partners Appleton, Wisconsin $2.57B AUM 16.81% 1-Year Est. Return
PCM
Palestra Capital Management New York $2.57B AUM 29.93% 1-Year Est. Return
HWA
Heritage Wealth Advisors Richmond, Virginia $2.56B AUM 19.48% 1-Year Est. Return

Trilogy Capital's Q2 2018 Portfolio in Review

As of Q2 2018, Trilogy Capital held 654 positions worth $743M, up 7.7% from $690M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Trilogy Capital deployed $51.3M of net new capital in Q2 2018, opening 146 new positions and adding to 170 existing holdings. Its largest new stake was Invesco S&P MidCap Low Volatility ETF: 6,487 shares worth $305K.

By sector, the portfolio is most concentrated in Utilities at 1.7% of assets, down from 1.8% a quarter earlier, followed by Consumer Staples and Healthcare.

On the sell side, the largest reduction was State Street SPDR S&P Dividend ETF, an estimated $339K trimmed.

  • Trilogy Capital's largest Q2 2018 buy was Invesco S&P MidCap Low Volatility ETF: 6,487 shares worth $305K.
  • Trilogy Capital added most to State Street SPDR Portfolio Aggregate Bond ETF in Q2 2018, an estimated $5.25M increase.
  • Trilogy Capital's biggest Q2 2018 reduction was State Street SPDR S&P Dividend ETF, cutting an estimated $339K.
  • Trilogy Capital fully exited State Street SPDR Portfolio Short Term Corporate Bond ETF in Q2 2018, selling an estimated $1.7M.
  • Trilogy Capital's ten largest holdings make up 53% of its $743M portfolio in Q2 2018.
  • Trilogy Capital opened 146 new positions and closed 37 in Q2 2018.
  • Trilogy Capital's portfolio value rose 7.7% quarter-over-quarter to $743M.

Based on Trilogy Capital's 13F filing for Q2 2018, filed 20 Aug 2018.